Related Experiment Video

Updated: May 26, 2026

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Approaches targeting K(V)10.1 open a novel window for cancer diagnosis and therapy

L A Pardo1, D Gómez-Varela, F Major

  • 1Max-Planck-Institute of Experimental Medicine, Hermann-Rein-Str. 3, 37075 Göttingen, Germany. pardo@em.mpg.de

Current Medicinal Chemistry
|December 30, 2011
PubMed

Insights

Potassium channel K(V)10.1 is a promising new cancer target, found in most solid tumors. Its cell-surface location offers potential for novel cancer treatments and diagnostics.

Area of Science:

  • Oncology
  • Molecular Biology
  • Ion Channel Research

Background:

  • K(V)10.1 is ectopically expressed in a majority of solid tumors.
  • Its cell-surface accessibility presents opportunities for cancer therapy and diagnostics.
  • K(V)10.1's mechanism may be independent of traditional cancer pathways like tyrosine kinases.

Purpose of the Study:

  • To review current data linking K(V)10.1 expression to various cancers.
  • To explore the potential of K(V)10.1 as a therapeutic and diagnostic target.
  • To propose novel strategies for cancer management leveraging K(V)10.1 properties.

Main Methods:

  • Literature review of studies on K(V)10.1 in cancer.
  • Analysis of K(V)10.1 expression patterns in solid tumors.
  • Discussion of potential therapeutic and diagnostic applications.

Main Results:

  • K(V)10.1 is a frequently overexpressed ion channel in solid tumors.
  • Its unique expression profile and cell-surface localization make it an attractive target.
  • Potential for developing targeted therapies independent of known oncogenic pathways.

Conclusions:

  • K(V)10.1 represents a novel and promising target for cancer treatment and diagnosis.
  • Further research into K(V)10.1 exploitation could lead to new therapeutic strategies.
  • Targeting K(V)10.1 offers a potential avenue for overcoming resistance to conventional therapies.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Screening Ion Channels in Cancer Cells06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...